Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Votre recherche
Pays: Canada,Germany,Italy,United Kingdom,United States,Sweden,Spain,Ireland,Austria,Netherlands
nct
MAJ Il y a 5 ans
A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
The purpose of this study is to allow patients to receive VELCADE™ (bortezomib) for Injection who experienced progressive disease(PD) while receiving high-dose dexamethasone from the M34101-039 study.
Pays
Austria
,
Belgium
,
Canada
,
France
,
Germany
,
Ireland
,
Israel
,
Italy
,
Netherlands
,
Spain
,
Sweden
,
United Kingdom
,
United States
,
Organes
Aucun
Spécialités
Aucun
Essai clos aux inclusions
Plus d'informations
nct
MAJ Il y a 5 ans
PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
This study will compare the efficacy of PS-341 versus high dose dexamethasone.
Pays
Austria
,
Belgium
,
Canada
,
France
,
Germany
,
Ireland
,
Israel
,
Italy
,
Netherlands
,
Spain
,
Sweden
,
United Kingdom
,
United States
,
Organes
Aucun
Spécialités
Aucun
Essai clos aux inclusions
Plus d'informations
1